Wells Fargo & Company MN boosted its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 158.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 216,049 shares of the construction company's stock after acquiring an additional 132,489 shares during the quarter. Wells Fargo & Company MN owned 0.26% of Aspen Aerogels worth $2,567,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the business. Morse Asset Management Inc bought a new stake in shares of Aspen Aerogels during the third quarter valued at about $264,000. AlphaQuest LLC raised its position in shares of Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock worth $135,000 after buying an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $164,000. Journey Strategic Wealth LLC bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $178,000. Finally, Ballentine Partners LLC increased its stake in shares of Aspen Aerogels by 19.2% during the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock valued at $189,000 after acquiring an additional 2,565 shares during the period. Institutional investors own 97.64% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. Barclays decreased their price target on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a research note on Wednesday, February 19th. B. Riley cut their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. Seaport Res Ptn cut shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. Canaccord Genuity Group cut their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday, February 14th. Finally, Roth Mkm decreased their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $19.11.
View Our Latest Stock Analysis on Aspen Aerogels
Aspen Aerogels Stock Down 0.2 %
Aspen Aerogels stock traded down $0.01 during mid-day trading on Wednesday, hitting $5.39. The company's stock had a trading volume of 1,305,160 shares, compared to its average volume of 1,932,078. The firm's 50 day moving average is $6.38 and its 200 day moving average is $11.41. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The company has a market cap of $442.55 million, a PE ratio of 33.69 and a beta of 2.35. Aspen Aerogels, Inc. has a 52-week low of $4.80 and a 52-week high of $33.15.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.
Aspen Aerogels Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.